Rabloc
Hypolipemiant. IHMG-CoA reductase inhibitor. Indicated to treat hypercholesterolemia, dyslipidemias, dysbetalipoproteinemia and for the prevention of more severe cardiovascular events in patients at high cardiovascular risk.
Therapeutic Area
Leukotriene Receptor Antagonist + Hypolipemiant HMG-CoA reductase inhibitor
Active Ingredient
Rosuvastatine
Line
Cardiometabolism
Pharmaceutical Forms
10 mg coated tablets x 30
20 mg coated tablets x 30
